Extracorporeal Membrane Oxygenation Machine Market - Global Market Share, Trends, Analysis and Forecasts, 2023 - 2032
Frequently asked questions about this report

The ECMO machine is used to pump and oxygenate patient’s blood outside the body and allows the heart and lungs to rest. When a patient is connected to an ECMO machine, the blood flows through tubes to an artificial lung, wherein oxygen is added and carbon dioxide is removed from the blood.

The demand for extracorporeal membrane oxygenation (ECMO) machine is expected to rise in coming years owing to focused efforts to reduce the mortality rate due to lung and cardiac failure.

North America contributed the largest share to the global extracorporeal membrane oxygenation machine market in 2019 and is anticipated to be the dominating geography throughout the forecast period. Rising number of patient suffering with cardiorespiratory disorders and presence of key manufacturers of ECMO machines are the key factor fueling the growth of ECMO machine market in North America.

Based on modality type, the extracorporeal membrane oxygenation machine market is segmented into veno-arterial, veno-venous, and others.

Key extracorporeal membrane oxygenation machine market players are MAQUET Holding B.V. & Co. KG, Medos Medizintechnik AG, Medtronic plc, Microport Scientific Corporation, Nipro Medical Corporation, Sorin Group, and Terumo Cardiovascular Systems Corporation.